Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Penumbra, Inc.

PENNYSE
Healthcare
Medical - Devices
$336.18
$1.19(0.36%)
U.S. Market opens in 16h 50m

Penumbra, Inc. (PEN) Stock Overview

Explore Penumbra, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap13.2B
P/E Ratio74.21
EPS (TTM)$4.50
ROE0.13%
Fundamental Analysis

AI Price Forecasts

1 Month$339.30
3 Months$315.29
1 Year Target$276.93

PEN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Penumbra, Inc. (PEN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of A, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 40.51, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $276.93.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 74.21 and a market capitalization of 13.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.30%
5-Day Change
-1.07%
1-Month Change
-0.97%
3-Month Change
7.69%
6-Month Change
23.20%
Year-to-Date (YTD) Change
8.59%
1-Year Change
28.92%
3-Year Change
33.29%
5-Year Change
17.20%
All-Time (Max) Change
713.58%

Contact Information

510 748 3200
One Penumbra Place, Alameda, CA, 94502

Company Facts

45,000 Employees
IPO DateSep 18, 2015
CountryUS
Actively Trading

Frequently Asked Questions